Evonik Raises 2026 Outlook After Strong Q2
Evonik reported adjusted EBITDA of €630 million for the second quarter of 2026, up 24% year over year, as supply-chain bottlenecks outside Europe contributed to higher volumes and selling prices. Revenue increased 11%, while both sales volumes and prices rose 7%.
The company raised its 2026 adjusted EBITDA outlook to €2.0 billion to €2.2 billion from its previous range of €1.7 billion to €2.0 billion. Net income for the quarter was €84 million, compared with €120 million a year earlier, while free cash flow improved to €49 million from negative €211 million.
Evonik said its Custom Solutions segment benefited from higher volumes and selling prices. Sales increased 4% to €1.422 billion, while adjusted EBITDA rose 7% to €271 million. The Additives business reported strong demand for products serving the paints and coatings industry, contributing to higher selling prices.
In Advanced Technologies, sales rose 9% to €1.647 billion and adjusted EBITDA increased 25% to €333 million. Evonik also reported improved crosslinker business and higher demand for precipitated silicas.
The company is continuing its efficiency program, with an additional reduction of approximately 3,200 positions planned from 2027 through 2029.
Evonik’s results provide coatings manufacturers with a direct indicator of demand and pricing conditions for specialty chemicals and additives used in coatings formulations. Follow PCI’s Raw Materials coverage for additional coatings supply and pricing developments.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
